GeorgeWildingMD

Clinical Trials

• Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma Start of enrollment: 1995 Mar 01

  Completed

  Phase 1

• SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer Start of enrollment: 1995 May 01

  Completed

  Phase 3

• Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer Start of enrollment: 1996 Jan 01

  Completed

  Phase 3

• Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer Start of enrollment: 1996 Oct 01

  Completed

  Phase 3

• Penclomedine in Treating Patients With Solid Tumors or Lymphoma Start of enrollment: 1997 Oct 01

  Completed

  Phase 1

• Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 1998 Feb 01

  Completed

  Phase 2

• Flavopiridol in Treating Patients With Recurrent Prostate Cancer Start of enrollment: 1998 May 01

  Completed

  Phase 2

• Doxercalciferol Before Surgery in Treating Localized Prostate Cancer Start of enrollment: 2001 Aug 01

  Completed

  Phase 2

• Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2002 Jun 01

  Completed

  Phase 1

• Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Oct 01

  Completed

  Phase 1

• 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors Start of enrollment: 2004 Jan 01

  Completed

  Phase 1

• Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors Start of enrollment: 2004 Mar 01

  Completed

  Phase 1

• Study of Satraplatin (JM-216) in Combination With Docetaxel Start of enrollment: 2007 Mar 01

  Terminated

  Phase 1

• Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors Start of enrollment: 2005 Jul 01

  Completed

  Phase 1

• PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma Start of enrollment: 2006 May 01

  Terminated

  Phase 1

• Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors Start of enrollment: 2007 May 22

  Completed

  Phase 1

• R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer Start of enrollment: 2007 Sep 01

  Completed

  Phase 1

• Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer Start of enrollment: 2002 Apr 01

  Terminated

  Phase 2

• A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine Start of enrollment: 2007 Apr 01

  Completed

  Phase 1

• Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors Start of enrollment: 2010 Jan 01

  Completed

  Phase 1

• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2010 Sep 01

  Completed

  Phase 1

• Join now to see all